Phibro Animal Health | PAHC - Ingresos Por Ventas





Ventas Cambio Fecha
Align Technology USD 1.05B 54.3M 2025-12
ANI Pharmaceuticals USD 247.06M 19.25M 2025-12
Assertio Holdings USD 29.2M 1.92M 2024-09
Aurora Cannabis CAD 94.19M 3.82M 2025-12
Bristol-Myers Squibb USD 12.5B 300M 2025-12
Canopy Growth CAD 74.54M 7.86M 2025-12
Corcept Therapeutics USD 202.12M 5.48M 2025-12
Eli Lilly USD 19.3B 1.7B 2025-12
Henry Schein USD 3.4B 60M 2025-12
Idexx Laboratories USD 1.09B 10M 2025-12
Knight Therapeutics CAD 133.11M 11.56M 2025-12
Merck USD 16.4B 880M 2025-12
Nektar Therapeutics USD 21.81M 2.32M 2025-12
Pacira USD 196.87M 17.35M 2025-12
Phibro Animal Health USD 373.91M 10.02M 2025-12
Prestige Brands USD 283.44M 9.34M 2025-12
Supernus Pharmaceuticals USD 211.6M 19.5M 2025-12
Zoetis USD 2.4B 0 2025-12